Clinical Services

CYKLOKAPRON (Anti-fibrinolytic- Tranexamic Acid)

CYKLOKAPRON (Anti-fibrinolytic- Tranexamic Acid)

ACCEPT:

  • If prescribed on an intermittent basis to prevent spotting & bleeding associated with the contraceptive implant or to decrease menstrual bleeding, as long as at least 48 hours have elapsed since taking the drug

DEFER:

  • If prescribed for any type of bleeding tendency or disorder
  • If on long term treatment with Cyklokapron

IBTS/MEDD/DSGDE/0001Attachment 4.118Ver 1.1

Sign up to Our Newsletter

Sign up to Our Newsletter

loading form...